Apollomics
APLM
NASDAQ
IPO2023
about APLM
Apollomics is a biopharmaceutical company focused on developing innovative cancer therapies, including antibody-drug conjugates and bispecific antibodies for targeted cancer immunotherapies.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $11.51 | $17.30 | $11.51 | $29.94M | 100.70K |